Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Plos Currents
|
August 23, 2011
A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors
Garrett Dancik, Dara Aisner, Dan Theodorescu
Clinics in Laboratory Medicine
|
September 23, 2022
Panel Sequencing for Targeted Therapy Selection in Solid Tumors
Nicholas Willard, Lynette Sholl, Dara Aisner
Leukemia & Lymphoma
|
February 26, 2008
Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience
Deirdre O'Mahony, Indranil Debnath, John Janik, et al.
Clinical Lung Cancer
|
July 31, 2021
Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non-small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy
David Chun Cheong Tsui, Dara Aisner, Hala Nijmeh, et al.
JCO Precision Oncology
|
January 13, 2022
Case of Metastatic Pheochromocytoma and Meningiomas in a Patient With Lynch Syndrome
Meryl D Colton, Kenneth Tompkins, Emily O'Donnell, et al.
Leukemia & Lymphoma
|
May 30, 2024
White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia
Jacob Fang, Grace Bosma, Dara Aisner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2019
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer
Jose M Pacheco, Dexiang Gao, Derek Smith, et al.
Breast Cancer Research : BCR
|
August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
Jennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
JCO Oncology Practice
|
June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
Christina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
The Journal of Clinical Investigation
|
January 17, 2023
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer
Shidan Wang, Ruichen Rong, Donghan M Yang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Plos Currents
|
August 23, 2011
A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors
Garrett Dancik, Dara Aisner, Dan Theodorescu
Clinics in Laboratory Medicine
|
September 23, 2022
Panel Sequencing for Targeted Therapy Selection in Solid Tumors
Nicholas Willard, Lynette Sholl, Dara Aisner
Leukemia & Lymphoma
|
February 26, 2008
Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience
Deirdre O'Mahony, Indranil Debnath, John Janik, et al.
Clinical Lung Cancer
|
July 31, 2021
Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non-small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy
David Chun Cheong Tsui, Dara Aisner, Hala Nijmeh, et al.
JCO Precision Oncology
|
January 13, 2022
Case of Metastatic Pheochromocytoma and Meningiomas in a Patient With Lynch Syndrome
Meryl D Colton, Kenneth Tompkins, Emily O'Donnell, et al.
Leukemia & Lymphoma
|
May 30, 2024
White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia
Jacob Fang, Grace Bosma, Dara Aisner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2019
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer
Jose M Pacheco, Dexiang Gao, Derek Smith, et al.
Breast Cancer Research : BCR
|
August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
Jennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
JCO Oncology Practice
|
June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
Christina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
The Journal of Clinical Investigation
|
January 17, 2023
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer
Shidan Wang, Ruichen Rong, Donghan M Yang, et al.
Page
of 2